Botulinum toxin type A success rates and predictive factors for favourable outcomes in paediatric patients with acquired esotropia
Botulinum toxin type A demonstrated a success rate of 51% at 6 months with pre-botulinum toxin type A esodeviation and early treatment identified as predictive factors for treatment success suggesting its clinical application.
Authors
- Juthamat Witthayaweerasak (ORCID: https://orcid.org/0000-0002-4153-6384)
- Supaporn Tengtrisorn (ORCID: https://orcid.org/0000-0003-1409-512X)
- Teechaya Nonboonyawat
- Orapan Aryasit (ORCID: https://orcid.org/0000-0002-1697-1798)
- Narisa Rattanalert (ORCID: https://orcid.org/0009-0002-9851-6883)
- Manupol Tangthongkum (ORCID: https://orcid.org/0000-0002-5718-3034)
- Penny Singha
Institutions
- Prince of Songkla University (TH)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1371/journal.pone.0332471
- Primary Topic
- Ophthalmology and Eye Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00